Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 3 of 11 for:    merck mk5172 hiv

Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03098121
Recruitment Status : Completed
First Posted : March 31, 2017
Last Update Posted : December 20, 2018
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
Taoyuan General Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 30, 2018
Actual Study Completion Date : November 30, 2018
Publications of Results:
Other Publications:

Publications automatically indexed to this study by Identifier (NCT Number):